fig2
From: Cancer Evo-Dev, a novel hypothesis derived from studies on hepatitis B virus-induced carcinogenesis
![<i>Cancer Evo-Dev</i>, a novel hypothesis derived from studies on hepatitis B virus-induced carcinogenesis](https://image.oaes.cc/0b96d430-e346-4b84-be06-1a60bdf488ed/2267.fig.2.png)
Figure 2. The HCC-related HBV mutations arehallmark molecular events during HBV-induced carcinogenesis. ASC: asymptomatic HBsAg carrier; CHB: chronic hepatitis B; LC: liver cirrhosis; HBeAg: hepatitis B e antigen; HCC: hepatocellular carcinoma